Filter
317
Text search:
COVID-19
and
hypertension
Featured
Recommendations
47
New Publications
7
Language
Document type
Studies & Reports
117
Guidelines
97
Manuals
30
Strategic & Response Plan
27
Fact sheets
22
Situation Updates
8
Training Material
5
No document type
5
Infographics
4
Brochures
1
Resource Platforms
1
Countries / Regions
Global
20
South Africa
17
Latin America and the Carribbean
15
India
13
Africa
11
Brazil
9
Ukraine
7
South–East Asia Region
7
Western and Central Europe
7
West and Central Africa
6
Kenya
5
Nigeria
4
Congo, Democratic Republic of
4
Ethiopia
4
Syria
4
Mozambique
4
Colombia
4
East and Southern Africa
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Ghana
3
Philippines
3
South Sudan
3
Peru
3
Chile
3
Venezuela
3
Russia
3
North America
3
Zimbabwe
2
Pakistan
2
Iraq
2
Germany
2
Zambia
2
China
2
Bangladesh
2
Angola
2
Mexico
2
Western Pacific Region
2
Vietnam
2
France
2
Sierra Leone
1
Senegal
1
Mali
1
Guinea-Bissau
1
Saudi Arabia
1
Uganda
1
Niger
1
Togo
1
Somalia
1
Nepal
1
Afghanistan
1
Turkey
1
Chad
1
Cambodia
1
Rwanda
1
Malawi
1
Sudan
1
Argentina
1
Eswatini/ Swaziland
1
Ecuador
1
Bolivia
1
Greece
1
Lesotho
1
Yemen
1
Asia
1
Eastern Europe
1
Palestine
1
Laos
1
Timor Leste/ East Timor
1
Moldova
1
Georgia
1
Mauritius
1
United Kingdom
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
132
Public Health
33
Clinical Guidelines
29
Women & Child Health
13
Capacity Building
9
Key Resources
4
Annual Report MEDBOX
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
171
NCDs
28
HIV
11
Planetary Health
11
Global Health Education
10
Caregiver
10
Conflict
8
TB
7
Refugee
6
Pharmacy
6
Mental Health
4
Health Financing Toolbox
2
Disability
1
Natural Hazards
1
Rapid Response
1
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guidelin
...
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with
...
Oxfam’s report found that Covid-19 has the potential to increase economic inequality in almost every country at once, the first time this has happened since records began over a century ago. It se
...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health system
...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021,
...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document
...
an approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity,
...
This document offers guidance to Member States in the African region on the key steps used to conduct contact tracing related to the COVID-19 response. It is to be used by national
...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (
...
To assess national-level responses to NCDs, WHO has implemented NCD country capacity surveys periodically since 2001. This report is the latest in that series. Since the first survey round, the NCD Country Capacity Survey (NCD CCS) has been conducted a further seven times, most recently in 2021. In
...
WHO Guideline on self-care interventions for health and well-being, 2022 revision: executive summary
recommended
A global shortage of an estimated 18 million health workers is anticipated by 2030, a record 130 million people are in need of humanitarian assistance, and there is the global threat of pandemics such as C
...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis
...
1 June 2020
Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation
...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on I
...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group o
...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform pra
...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Im
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the b
...
The target audience for this training course is non-clinicians such as Home Based Carers, Community Caregivers, Youth Care Workers, Peer educators, Community Health Workers etc. primarily those who will be providing adherence counselling to clients with HIV, TB,
...
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting for variations in the benefits
...
